Stocks TelegraphStocks Telegraph
Stock Ideas

INVO Financial Statements and Analysis

NASDAQ : INVO

INVO Bioscience, Inc.

$0.83
-0.017-2.00%
Open: 4:00 PM
Not Actively Trading
68.97
B-ESG ScoreESG Rating

INVO FINANCIAL STATEMENTS

An instrumental part of fundamental analysis is measuring key indicators of an asset, which are the factors that can influence its value and price. However, sometimes investors show more interest in financial statements with other factors to determine whether investing in that company is the right decision. Financial statements of a company include:

  • Balance Sheet
  • Income Statement
  • Cash Flow Statement

INVO Income Statement

A company's income statement helps investors and business owners determine whether the company is profitable or losing money. Profitability is a key factor investors consider before investing in a stock. Income statements provide them with information about a company's profitability over time. The statement also enables them to observe trends in company spending and earnings since it breaks down individual costs and revenues. Income statements also provide details on where a company's money is going when it isn't profitable or its profits fluctuate.

Date2024-06-302024-03-312023-12-312023-09-302023-06-30
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202320232023
periodQ2Q1Q4Q3Q2
revenue1.837M1.576M1.382M974.894K315.902K
cost of revenue1.092M1.077M886.75K580.968K255.419K
gross profit744.611K499.092K495.004K393.926K60.483K
gross profit ratio0.4050.3170.3580.4040.191
research and development expenses04.88K5.907K2.668K83.85K
general and administrative expenses00000
selling and marketing expenses00000
selling general and administrative expenses2.648M1.441M1.856M1.257M2.043M
other expenses230.338M226.96K180.39K20.504K19.706K
operating expenses2.648M1.445M2.003M1.28M2.126M
cost and expenses3.74M2.523M2.89M1.861M2.382M
interest income00-391.781K0175.192K
interest expense369.612K181.295K182.043K352.085K175.192K
depreciation and amortization230.338K226.96K141.598K20.504K-38.154K
ebitda-1.645M-1.186M-1.395M-873.949K-2.062M
ebitda ratio-0.911-0.456-1.01-0.896-6.528
operating income-1.903M-946.37K-1.508M-886.29K-2.066M
operating income ratio-1.036-0.60-1.092-0.909-6.54
total other income expenses net-342.257K-648.303K-281.236K-8.179K3.523K
income before tax-2.245M-1.595M-1.972M-1.247M-2.238M
income before tax ratio-1.222-1.012-1.427-1.279-7.083
income tax expense2.001.836K23.035K1.886K2.865K
net income-2.245M-1.597M-1.995M-1.248M-2.241M
net income ratio-1.222-1.013-1.444-1.281-7.092
eps-0.62-0.42-1.27-0.70-3.06
eps diluted-0.62-0.42-1.27-0.70-3.06
weighted average shs out3.61M3.802M1.566M1.777M732.255K
weighted average shs out dil3.61M3.802M1.566M1.777M732.255K
Graph

INVO Balance Sheet

Balance sheet summarizes a company's financials and can be used as a basis by investors to determine the value of a company. It shows the value of the stock, as well as the assets and liabilities of the company. A company's balance sheet displays how its assets are put to use and how those assets are financed, based on the liabilities section. Both investors and analysts analyze a company's balance sheet to determine how it allocates its resources.

Date2024-06-302024-03-312023-09-302023-06-302023-03-31
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202320232023
periodQ2Q1Q3Q2Q1
cash and cash equivalents942.934K475.125K1.056M112.485K2.188M
short term investments00000
cash and short term investments942.934K475.125K1.056M112.485K2.188M
net receivables257.21K176.888K116.781K74.908K99.72K
inventory250.066K266.454K254.22K280.018K270.919K
other current assets945.853K806.479K365.227K374.714K250.878K
total current assets2.396M1.725M1.792M842.125K2.81M
property plant equipment net3.056M3.781M6.63M4.664M2.168M
goodwill5.879M5.879M8.225M00
intangible assets3.685M3.889M1.75M00
goodwill and intangible assets9.564M9.768M9.975M00
long term investments3.016M3.043M1.079M1.132M1.174M
tax assets-14.341B-5.541M-6.937M00
other non current assets14.341B5.541M6.937M-5.797M-3.341M
total non current assets15.636M16.593M17.684M5.797M3.341M
other assets00000
total assets18.032M18.318M19.476M6.639M6.151M
account payables2.378M2.798M2.442M770.00K1.847M
short term debt1.697M2.028M2.088M1.261M1.335M
tax payables00000
deferred revenue416.745K513.425K229.921K161.187K46.746K
other current liabilities3.497M3.616M123.432K2.277M1.221M
total current liabilities7.989M8.956M4.884M4.469M4.45M
long term debt3.679M4.352M6.717M3.873M1.611M
deferred revenue non current00000
deferred tax liabilities non current001.949K1.949K1.949K
other non current liabilities5.00M5.00M7.50M00
total non current liabilities8.679M9.352M14.219M3.875M1.613M
other liabilities00000
capital lease obligations2.507M3.138M6.008M4.10M1.845M
total liabilities16.668M18.308M19.103M8.344M6.063M
preferred stock7.506M6.50M000
common stock386.00262.00247.0083.001.397K
retained earnings-61.91M-59.415M-55.823M-54.575M-52.334M
accumulated other comprehensive income loss-1.506B-500.00K000
other total stockholders equity55.767M52.925M56.196M52.869M52.421M
total stockholders equity1.364M10.155K372.799K-1.705M88.466K
total equity1.364M10.155K372.799K-1.705M88.466K
total liabilities and stockholders equity18.032M18.318M19.476M6.639M6.151M
minority interest00000
total investments3.016M3.043M1.079M1.132M1.174M
total debt5.377M6.38M8.806M5.134M2.946M
net debt4.434M5.905M7.75M5.022M757.86K
Graph

INVO Cash Flow

A cash flow statement is regarded as a valuable indicator of profitability and the long-term outlook for a company. It assists the company in evaluating whether it has sufficient funds to cover its expenses. Essentially, a cash flow statement represents an organization's financial health. The cash flow statement, which measures the business's ability to operate in the short as well as long term, is broken down into operating, investing, and financing activities.

Date2024-06-302024-03-312023-09-302023-06-302023-03-31
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202320232023
periodQ2Q1Q3Q2Q1
deferred income tax008.163K-3.788K0
stock based compensation1.10M213.843K265.473K426.254K522.237K
change in working capital-809.548K285.107K-649.172K44.082K552.12K
accounts receivables-80.322K-36.338K-41.873K24.812K-22.571K
inventory16.388K-1.947K25.798K-9.099K-7.317K
accounts payables-436.671K472.106K-90.009K-65.515K498.169K
other working capital-308.943K-148.714K-543.088K93.884K83.839K
other non cash items2.33M843.988K356.161K167.718K251.115K
net cash provided by operating activities-1.456M-260.556K-1.247M-1.644M-1.148M
investments in property plant and equipment-55.131K-49.698K-108.217K-261.505K0
acquisitions net50.00K25.59K-2.15M0-8.447K
purchases of investments0000-8.447K
sales maturities of investments00000
other investing activites50.00K-24.108K008.447K
net cash used for investing activites-5.131K-24.108K-2.258M-261.505K-8.447K
debt repayment-143.549K-27.366K-993.725K-190.151K-170.00K
common stock issued2.072M500.00K2.996M20.296K2.709M
common stock repurchased00000
dividends paid00000
other financing activites1.929M27.366K2.446M-1.00716.376K
net cash used provided by financing activities1.929M527.366K4.449M-169.856K3.255M
effect of forex changes on cash00-982.547K2.068M0
net change in cash467.809K242.701K943.059K-2.076M2.098M
cash at end of period942.934K475.125K1.056M112.485K2.188M
cash at beginning of period475.125K232.424K112.485K2.188M90.135K
operating cashflow-1.456M-260.556K-1.247M-1.644M-1.148M
capital expenditure-55.131K-49.698K-108.217K-261.505K0
free cash flow-1.511M-310.254K-1.356M-1.906M-1.148M
Graph

Frequently Asked Questions

How did INVO Bioscience, Inc. do last quarter? What was its Total Revenue and Cost of Revenue?

A company's Total Revenue reveals how much money it generates before any expenses or deductions are made. As a result, this metric informs investors/stakeholders how much money the business makes. Tracking and understanding it is essential for evaluating a company's growth. As opposed to revenue, Cost of Revenue is any expenses a business incur to generate revenue. There can be high revenue in a business, but if the costs are high, it won't make a profit and will go out of business when money runs out. Therefore, INVO generated $1.84M in revenue last quarter, while its costs came in at $1.09M.

Last quarter, how much Gross Profit did INVO Bioscience, Inc. report?

A business's Gross Profit is a key indicator of its profitability and financial performance. In other words, it reflects how efficiently a business uses labor, raw materials, and other resources. INVO Bioscience, Inc. reported a $744.61K Gross Profit for the quarter ended Jun 30, 2024.

Have INVO's Total Operating Expenses and Operating Income been favorable recently?

Operational Expenses represent the costs a company must incur to generate revenue, which is the ultimate goal of a business, whereas Operating Income shows the revenue left after operational direct and indirect costs have been deducted. INVO incurred $2.65M worth of Operating Expenses, while it generated -$1.90M worth of Operating Income.

How much Net Income has INVO posted recently?

The Net Income of a company is one of the factors investors consider when investing in the company. According to recent earnings report from INVO Bioscience, Inc., the company generated -$2.25M in Net Income. When a company has a history of consistent net income, investors are more likely to invest in it since they know they will get a return.

At the end of the last quarter, how much Cash and Equivalents did INVO Bioscience, Inc. have?

The amount of Cash and Cash Equivalents is an effective indicator of the financial strength and well-being of a company. An excess cash situation occurs when a company has more cash and cash equivalents than it needs for operating activities. The amount of Cash and Cash Equivalents available to INVO Bioscience, Inc. as of the end of the last quarter was $942.93K.

What are INVO's Total Net Receivables for the last quarter?

Total Net Receivables are a company's outstanding debts to its customers. Therefore, it refers to the amount that a company expects to collect from its customers. The higher a company's net receivables are, the more confident it is that it can collect money from its debtors. As of the end of the last quarter, INVO had Total Net Receivables of $257.21K.

In terms of Total Assets and Current Assets, where did INVO Bioscience, Inc. stand at?

An asset with an economic value within a year is considered a current asset. Total assets, however, also include long-term fixed assets, intangible assets, and other non-current assets. The current Assets of INVO were $2.40M, while the Total Assets stand at $18.03M.

As of the last quarter, how much Total Debt did INVO Bioscience, Inc. have?

The total debt of a business refers to how much it borrows. A company's current and long-term liabilities are added together to calculate its Total Debt. A debt ratio may be taken into account on a balance sheet by financial lenders, investors, and business leaders when making informed decisions about future loans or investments. The total amount of INVO's debt was $5.38M at the end of the last quarter.

What were INVO's Total Liabilities during the last reported quarter?

A company's total liabilities are the sum of all debts it is liable for, including any off-balance shee liabilities it may incur. This can be calculated by adding up all short-term and long-term liabilities. In its last quarter, INVO reported total liabilities of $16.67M.

How much did INVO's Working Capital change over the last quarter?

Working Capital Change for INVO was -$809.55K over the last quarter. Working Capital Change refers to the difference between net working capital amounts at the end of one accounting period and the end of another. It tells investors/stakeholders how much the company's cash flow will differ from its Net Income (i.e., after-tax profits). More powerful companies often have positive Change in Working Capital numbers as they have increased control over collecting cash from customers and delaying payments to suppliers.

INVO generated how much cash from operating activities?

An operating cash flow statement usually contains cash from operating activities in the first section. An organization's cash from operating activities refers to the money it takes in and takes out as a result of its regular business operations. INVO generated -$1.46M of Cash from Operating Activities during its recently reported quarter.

What was INVO's latest reported Net Change in Cash?

An increase or decrease in cash and cash equivalent balances within a specified period is considered the net change in cash in a cash flow statement. Furthermore, it takes into account cash changes as a result of investments, financing, and operating activities. INVO reported a $467.81K Net Change in Cash in the most recent quarter.

logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph